Inovio Pharmaceuticals (NYSE:INO) and its subsidiaries develop synthetic vaccines to prevent and treat cancers and infectious diseases. The company’s SynCon® vaccines are designed to universally protect against unmatched rapidly mutating viruses, or break tolerance against cancers, and cannot cause the disease. The company’s clinical programs include human papillomavirus/cervical cancer (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), and hepatitis C virus and human immunodeficiency virus vaccines. For more information visit the company’s Web site at www.inovio.com

Marcum offers an extensive range of professional services and a high degree of specialization. In addition to traditional accounting, assurance, and tax, including domestic and international tax planning and preparation, the firm’s professional services include mergers and acquisition planning, family office services, forensic accounting, and litigation support. For more information on Marcum, visit www.marcumllp.com

Let us hear your thoughts below: